Skip to content
DraconiticResearch
Search Sources API
194,067 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BYMedical sciences (Basel, Switzerland)

MicroRNAs in Cutaneous Melanoma: Biological Roles, Clinical Utility, and Future Directions

  • Adrian-Ilie Pașcu1
  • Maximilian-Vlad Muntean2
  • Claudia Diana Gherman3
  • Vlad Alexandru Gâta4
  • Simona Corina Şenila1
  • Salomea-Ruth Halmágyi1
  • Loredana Ungureanu1
4 affiliations
  1. 1Department of Dermatology, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania; (A.-I.P.); (S.C.Ş.); (S.-R.H.); (L.U.)
  2. 2Department of Plastic Surgery, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania
  3. 3Department of Surgery-Practical Abilities, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania;
  4. 4Department of Oncological Surgery, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania;
Read full textPDFCite

Related

  1. Machine learning based regulatory T cells related gene signature for predicting the clinical outcome and immunotherapy benefits in skin cutaneous melanoma
    Yuzhi Zheng, Xinnuo Chen, Zijian Wu +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  2. Real-World Direct Medical Costs and Clinical Outcomes of Immunotherapy and Targeted Therapy for Cutaneous Melanoma: A Bottom-Up Cost-of-Illness Study in a Public Healthcare System
    Aleksandra M. Kovačević, Tijana G. Stanojković, Milijana N. Miljković +4
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  3. Poly(ADP-Ribose) Polymerase Inhibition in Melanoma: Biological Rationale, Emerging Clinical Evidence, and Biomarker Selection
    Chana Peysin, Tamara A. Sussman
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  4. Interferon Therapy in Acute Myeloid Leukemia: Biological Rationale, Clinical Evidence, and Future Directions
    Jan Philipp Bewersdorf, Hsin-An Hou, Evelyn Yingtzu Yen +4
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  5. Bipolar androgen therapy in castration-resistant prostate cancer: Biological rationale, clinical evidence, and future directions.
    Paul M Rival, Jeffrey Jiang, Liang G Qu +3
    Current urologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{pașcu2026micrornas,
  title = {{MicroRNAs in Cutaneous Melanoma: Biological Roles, Clinical Utility, and Future Directions}},
  author = {Adrian-Ilie Pașcu and Maximilian-Vlad Muntean and Claudia Diana Gherman and Vlad Alexandru Gâta and Simona Corina Şenila and Salomea-Ruth Halmágyi and Loredana Ungureanu},
  journal = {Medical sciences (Basel, Switzerland)},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13706929},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - MicroRNAs in Cutaneous Melanoma: Biological Roles, Clinical Utility, and Future Directions
AU  - Adrian-Ilie Pașcu
AU  - Maximilian-Vlad Muntean
AU  - Claudia Diana Gherman
AU  - Vlad Alexandru Gâta
AU  - Simona Corina Şenila
AU  - Salomea-Ruth Halmágyi
AU  - Loredana Ungureanu
PY  - 2026
DA  - 2026/09/23
JO  - Medical sciences (Basel, Switzerland)
UR  - https://europepmc.org/article/PMC/PMC13706929
SN  - 2076-3271
ER  -